Ashwagandha is not a blood thinner in the way that medications like warfarin or aspirin are, but one of its active compounds does show anticoagulant and antiplatelet properties in laboratory and animal research. At typical supplement doses (300 to 600 mg daily), human trials have not detected changes in blood clotting markers. Still, the biological potential is real enough that the distinction matters, especially if you take blood-thinning medications or have surgery coming up.
What the Lab Research Shows
The compound behind ashwagandha’s potential blood-thinning effect is withaferin A, a steroidal lactone that makes up a portion of the plant’s active ingredients. A study published in the journal Thrombosis Research tested withaferin A directly and found it inhibited platelet aggregation (the clumping that starts a clot), slowed fibrin polymerization (the process that builds the clot’s structure), and prolonged both major clotting time measurements. In animal models, it also extended bleeding time and reduced thrombus formation in blood vessels.
Beyond clotting itself, withaferin A influenced the balance between two proteins that regulate how your body breaks down clots after they form. It lowered the ratio of a clot-preserving protein to a clot-dissolving one, meaning it shifted the balance toward keeping blood flowing rather than letting clots persist. Researchers concluded that withaferin A has genuine antithrombotic activity across multiple pathways, not just one narrow mechanism.
Why Supplement Doses Tell a Different Story
Lab studies isolate and concentrate individual compounds, which means the doses of withaferin A tested are not necessarily what you get from swallowing a standard ashwagandha capsule. A whole-root extract contains withaferin A alongside dozens of other withanolides, alkaloids, and plant compounds, all in much smaller concentrations than what researchers use to demonstrate an effect in a petri dish or a mouse.
Multiple randomized controlled trials have given healthy adults 300 to 600 mg of ashwagandha extract daily for 8 to 12 weeks. None of those trials found changes in hematological parameters, which is the category that would flag a blood-thinning effect. No serious adverse events were reported, and vital signs stayed stable throughout. A separate safety trial using 500 mg twice daily for 30 days in healthy volunteers reported zero adverse effects and confirmed tolerability. Notably, that study excluded anyone with a history of easy bruising or bleeding from participating, which suggests researchers were aware of the theoretical concern even though it didn’t materialize in practice.
In short, the isolated compound can thin blood in a lab. The whole supplement, at normal doses, has not been shown to do so in people.
Interaction Risk With Blood-Thinning Medications
The gap between lab findings and real-world supplement doses does not mean you can ignore the interaction risk entirely. If you already take anticoagulant or antiplatelet medication, adding a supplement with demonstrated anticoagulant compounds, even at lower concentrations, could theoretically push the overall effect further than intended. This is the same logic behind warnings about fish oil, turmeric, and ginger alongside blood thinners: each one alone may not meaningfully thin your blood, but stacking them on top of a prescription anticoagulant changes the math.
No published case reports describe spontaneous bruising, nosebleeds, or abnormal bleeding directly caused by ashwagandha supplements. The commonly reported side effects from clinical literature are mild and unrelated to bleeding: occasional drowsiness, mild stomach discomfort, dry mouth, and nasal congestion. But the absence of case reports is not the same as proof of safety in combination with medications, since supplement interactions are notoriously underreported.
Ashwagandha Before Surgery
Surgeons routinely ask patients to stop supplements that could affect clotting in the weeks before a procedure. Ashwagandha falls into this category. Guidelines from integrative medicine reviews recommend notifying your surgeon about ashwagandha use and following their discontinuation timeline before any surgical procedure. Most herbal supplements with theoretical anticoagulant properties are stopped one to two weeks before surgery, though your surgeon may adjust that window depending on the type of procedure and your other medications.
The concern is not limited to bleeding. Ashwagandha also modulates immune responses, which adds a separate reason surgeons want to know about it before operating.
The Bottom Line on Blood Thinning
Ashwagandha contains a compound with real anticoagulant activity, but standard supplement doses have not produced measurable blood-thinning effects in human trials. The practical risk sits in two specific situations: combining ashwagandha with prescription blood thinners, and continuing it too close to a surgical procedure. Outside those scenarios, the evidence so far suggests that typical doses in healthy adults do not alter clotting in a clinically meaningful way.